For Immediate Release:

VITAMIN C DOES NOT CAUSE KIDNEY STONES

(Orthomolecular Medicine News Service, July 5 2005)

By Steve Hickey, PhD and Hilary Roberts, PhD.

(OMNS) It is strange how some medical authors seem desperate to show
that vitamin C causes harm. One recurrent scare story is that vitamin C
might cause kidney stones. However, although such warnings pop up
regularly, these reports do not demonstrate an increase in the number
or size of stones; instead, they rely on vague indicators of improbable
risk.

The authors of such uncritical papers have probably not read the
literature, for this is an old story. Decades ago, the idea that
vitamin C causes kidney stones formed part of the medical attack on
Linus Pauling. While it was initially a reasonable hypothesis,
unexpected kidney stones are not found in people taking large amounts
of vitamin C. (1,2)

There is no evidence that vitamin C causes kidney stones. Indeed, in
some cases, high doses may be curative. (3) A recent, large-scale,
prospective study followed 85,557 women for 14 years and found no
evidence that vitamin C causes kidney stones. (4) There was no
difference in the occurrence of stones between people taking less than
250 milligrams per day and those taking 1.5 grams or more. This study
was a follow up of an earlier study on 45,251 men. This earlier study
indicated that doses of vitamin C above 1.5 grams reduce the risk of
kidney stones. (5) The authors of these large studies stated that
restriction of higher doses of vitamin C because of the possibility of
kidney stones is unwarranted.

People with recurrent stone formation may have an unusual biochemistry,
leading to increased production of oxalate from vitamin C. (6) Oxalate
and urate can accumulate in kidney stones. In practice, there is an
increased excretion of both oxalate and urate with gram level doses of
vitamin C (ascorbate). Various authors over the years have used this
increase to predict that vitamin C will cause kidney stones; however,
these predictions have never been confirmed.

Around three quarters of all kidney stones are composed of calcium
oxalate; unlike some other stone types, these can form in acidic urine.
Although vitamin C does increase the production of oxalate in the body,
there is no evidence that it increases stone formation. It could even
have the reverse effect, for several reasons. Firstly, vitamin C tends
to bind calcium, which could decrease its availability for formation of
calcium oxalate. Secondly, vitamin C has a diuretic action: it
increases urine flow, providing an environment that is less suitable
for formation of kidney stones. Finally, stone formation appears to
occur around a nucleus of infection. High concentrations of vitamin C
are bactericidal and might prevent stone formation by removing the
bacteria around which stones form.

Vitamin C could also prevent other types of kidney stones. Less common
forms of stone include uric acid stones (8%), that form in gout, and
cystine stones (1%), which can occasionally be formed in children with
a hereditary condition; these stones are not side effects of vitamin C.
Other stones include those made from calcium phosphate (5%), which
dissolve in a vitamin C solution. Acid urine, produced by ascorbate,
will also dissolve the struvite stones (magnesium ammonium phosphate)
that often occur in infected urine.

Recently, Linda Massey and colleagues from Washington State University
have claimed that vitamin C increases the risk of kidney stones. (7)
Their paper illustrates how the claims of risk have little basis in
fact. Massey claims that vitamin C supplementation can increase the
amount of oxalate. Vitamin C can increase oxalate absorption and, if
degraded in the body, ascorbate can be converted into oxalate. However,
while oxalate is a constituent of some types of kidney stone, an
increase in its concentration does not mean that more or larger kidney
stones will be formed. The formation of kidney stones is influenced by
many factors and, as we have seen, vitamin C might be predicted to
inhibit several aspects of stone generation. Massey suggests that this
increase in oxalate may increase the risk of stones. This is a weak
suggestion, which is contradicted by substantial evidence, quoted
above.

This evidence suggests that a high vitamin C intake has no effect on
the number of kidney stones, or may even be protective.

Massey links oxalate to risk by use of a measure called the Tiselius
Risk Index or TRI. (8) However, this measure is applied incorrectly.
Indeed, in the presence of high doses of vitamin C, this index should
be modified to accommodate the formation of calcium ascorbate in urine.
The TRI measure was developed for subjects that had not been
supplemented with vitamin C and, on the basis of simple chemistry,
requires modification for use with ascorbate supplementation. Since
vitamin C might affect many stages of stone formation and growth,
application of the TRI measure to supplemented individuals is suspect.
The TRI is applied in this case as a predictive measure, for which it
has not been validated. Furthermore, the TRI is derived from the
concentration of calcium oxalate, making the argument for increased
risk rather circular. Even more importantly, Massey uses the TRI to
predict an increased theoretical risk, which substantial evidence
indicates is absent.

In Massey's study, 29 stoneformers and 19 non-stoneformers were
supplemented with one gram of vitamin C, twice each day. After five
days on a low-oxalate diet, the subjects were challenged before
breakfast with 136 mg oxalate, including 18 mg oxalic acid. They
remained on the low oxalate diet for the remainder of the day. Of the
48 people, 12 stoneformers and 7 non-stoneformers had an increased
total oxalate excretion of greater than 10% after supplementation.

However, the number or size of kidney stones did not increase.

Also, we can note that seven of the subjects who showed an increased
level of oxalate were not stoneformers. The important question of why
some people form kidney stones, and others do not, was neatly
sidestepped.

Massey's argument boils down to the vague idea that there could
possibly be an increase in kidney stone formation in some rare people.
This might be the case if vitamin C increased oxalate without affecting
any other part of the process; this is known to be false. If this is
the sort of evidence presented as acceptable, we can be comfortable
with the claim that the areas of the moon not yet visited by man may be
made of green cheese.

References:

1) Hickey S. Roberts H. (2004) Ascorbate: the Science of Vitamin C,
Lulu press.

2) Hickey S. Roberts H. (2004) Ridiculous Dietary Allowance, Lulu
press.

3) McCormick W.J. (1946) Lithogenesis and hypovitaminosis, Medical
Record, 159, 410-413.

4) Curhan, G. C., Willett, W. C., Speizer, F. E., Stampfer, M. J.
(1999) Megadose Vitamin C consumption does not cause kidney stones.
Intake of vitamins B6 and C and the risk of kidney stones in women, J
Am Soc Nephrol., Apr, 10, 4, 840-845.

5) Curhan G.C. Willett W.C. Rimm E.B. Stampfer M.J. (1996) A
prospective study of the intake of vitamins C and B6, and the risk of
kidney stones in men, J Urol, 155(6), 1847-1851.

6) Chalmers A.H, Cowley DM, Brown J.M. (1986) A possible etiological
role for ascorbate in calculi formation, Clin Chem, 32(2), 333-336.

7) Massey L.K. Liebman M. Kynast-Gales S.A. (2005) Ascorbate increases
human oxaluria and kidney stone risk, J Nutr, 135(7), 1673-1677.

8) Tiselius H.G. (2000) Stone incidence and formation, Clinical Urology
26(5), 452-462.

What is Orthomolecular Medicine?

Linus Pauling defined orthomolecular medicine as "the treatment of
disease by the provision of the optimum molecular environment,
especially the optimum concentrations of substances normally present in
the human body." Orthomolecular medicine uses safe, effective
nutritional therapy to fight illness. For more information:
http://www.orthomolecular.org

Take the Orthomolecular Quiz at
http://www.orthomolecular.org/quiz/index.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit
and non-commercial informational resource.

Editorial Review Board:

Abram Hoffer, M.D., Ph.D.

Harold D. Foster, Ph.D.

Bradford Weeks, M.D.

Carolyn Dean, M.D., N.D.

Eric Patterson, M.D.

Andrew W. Saul, contact person. email: omns@orthomolecular.org .

To UNSUBSCRIBE: http://www.orthomolecular.org/unsubscribe.html

To subscribe at no charge: http://orthomolecular.org/subscribe.html

Date: 05-Jul-05